Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    17296825 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents
Conditions: Coronary Heart Disease;   Coronary Restenosis
Interventions: Drug: Oral sirolimus;   Device: Drug Eluting stent
2 Completed The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions.
Condition: Coronary Artery Disease
Interventions: Device: drug-eluting stent;   Device: bare-metal stent
3 Completed Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)
Condition: Coronary Artery Disease
Interventions: Device: CYPHER Sirolimus-Eluting Stent;   Device: Uncoated BX VELOCITY Balloon-Expandable Stent
4 Completed The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions.
Condition: Coronary Artery Disease
Interventions: Device: sirolimus-coated Bx Velocity stent;   Device: uncoated Bx Velocity stent
5 Completed The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study.
Condition: Coronary Artery Disease
Interventions: Device: Sirolimus coated Bx Velocity™;   Device: Bare metal Bx Velocity™

Indicates status has not been verified in more than two years